香茅精油的抑菌和抗氧化活性研究

选用产自福建厦门的香茅(Cymbopogon nardus),测定香茅精油对白色粘性沙雷氏菌、红色粘性沙雷氏菌、大肠杆菌、金黄葡萄球菌、铜绿假单胞菌和紫色杆菌等6种菌的抑菌活性,并利用ABTS^.+自由基清除法以及超氧阴离子清除法研究香茅精油的抗氧化活性。结果表明,新鲜香茅精油的平均提取率为0.29,对6种供试菌种都有较高的抑制作用,其中对紫色杆菌的抑制活性最强,且香茅精油有极高的清除ABTS^.+自由基以及超氧阴离子自由基的能力,证明香茅精油具有广谱抑菌活性及强抗氧化活性。     

入侵植物三裂叶豚草在中国的潜在适生区预测

[目的] 三裂叶豚草是中国重点防控的入侵植物,研究其潜在的适生区分布格局变化对预警防控具有重要意义。[方法] 基于MaxEnt优化模型预测当前及未来（RCP2.6、RCP4.5、RCP8.5）气候情景下三裂叶豚草潜在的地理分布格局。[结果] 当调控倍频（RM）=3.5,FC（特征组合）=LQH（线性、二次型、片段化组合）时为最优模型,MaxEnt模型的预测结果较准确,受试者工作特征曲线下的面积（AUC值）达0.9287;综合8种途径评估出人类活动因子（hfp,贡献率69%）、等温性（bio3,贡献率8.9%）、温度季节变动系数（bio4,贡献率2.9%）、年降水量（bio12,贡献率7.3%）和海拔（ELEV,贡献率3.7%）是制约三裂叶豚草潜在地理分布的主要环境因子;在当前气候情景下,三裂叶豚草的高适生区主要集中在东北平原、江淮地区、京津冀、山东半岛等经济发达地区。[结论] 在未来气候变化情景下,三裂叶豚草在我国的潜在适生区范围总体呈现不同程度的缩减,即丧失率大于增加率;三裂叶豚草将有向南迁移的趋势;最冷月最低温度（bio6）是最不相似变量分析中出现频次最高的因子,表明温度因素对三裂叶豚草潜在地理分布变迁起到重要制约作用。本研究结果可为三裂叶豚草的预防和控制提供理论基础。     

西伯利亚蝗抗菌肽基因的克隆及表达特性研究

[目的]扩增西伯利亚蝗Gomphocerus sibiricus抗菌肽(attacin)基因,并对其进行生物信息学分析,同时分析西伯利亚蝗不同组织中抗菌肽基因的差异表达.[方法]基于RACE技术从西伯利亚蝗中克隆得到抗菌肽,利用生物信息学软件对西伯利亚蝗抗菌肽的一级结构、二级结构、三级结构、系统进化和亚细胞定位进行分析.采用实时荧光定量PCR技术检测了西伯利亚蝗抗菌肽基因在马氏管、中肠、后肠、脂肪体和唾液腺中的相对表达量.[结果]克隆获得的抗菌肽基因的开放阅读框为282 bp,编码93个氨基酸,其编码蛋白预测理论分子量为9.98 ku,等电点为9.26.抗菌肽氨基酸序列中存在信号肽序列.基因定量分析显示,抗菌肽基因在西伯利亚蝗的中肠中表达量最高.[结论]attacin在西伯利亚蝗成虫不同组织中差异表达,提示其消化道在防御病原微生物的入侵中起着重要的作用.     

不同采收期罗布麻和白麻药材化学成分的差异分析

建立高效液相色谱法,分别测定不同采收期的新疆产罗布麻和白麻药材中绿原酸、金丝桃苷、异槲皮苷、三叶豆苷、紫云英苷、芦丁和白麻苷的含量,进而分析2种药材的最佳采收期。发现不同采收期的新疆产罗布麻和白麻药材中绿原酸、金丝桃苷、异槲皮苷、三叶豆苷、紫云英苷、芦丁和白麻苷的含量存在一定差异,并且罗布麻和白麻呈现出不同特点。以《中国药典》中罗布麻含量测定项下的金丝桃苷为指标,罗布麻和白麻的最佳采收期都是6、7月;但是,以7个成分的总含量和6个黄酮的总含量为指标,罗布麻的最佳采收期是8、9月,白麻的最佳采收期仍是6、7月。该结果可为确定罗布麻和白麻药材的采收时间提供一定参考。     

快速STR分型在法医DNA分析中的应用研究进展

STR分型是目前世界通用的DNA指纹分析方法.传统的分型方法包括DNA提取、DNA定量、PCR扩增和对扩增后的STR片段进行检测和分析,耗时较长(8¹0 h).一些情况下很难满足案件的实际需求.法医学家们在加快STR分型的方法研究一直不懈努力.现从快速提取DNA、无提取直接PCR、快速PCR、微流控芯片技术在STR快速分型方面的应用四方面,对近年来出现的可进行快速STR分型的新技术、新方法进行综述.     

4种快速PCR检测试剂法医学应用的初步研究

采用快速PCR扩增,探索其法医学应用价值.将AmpFLSTRIdentifiler试剂盒分别与4种不同的快速PCR检测试剂联合构建快速PCR体系,以9947A为模板,采用各自优化的循环参数进行扩增,并将各分型结果与常规方法进行比较,结果表明:联合构建的4种快速PCR体系均可获得与常规方法一致的DNA分型结果,扩增用时最短可减少至22 min.可见应用快速PCR方法进行扩增,可获得与常规方法一致的STR分型,并且显著缩短扩增时间,提高DNA分型速率.     

人p53启动子萤光素酶报告基因的构建及其活性测定

目的：克隆p53基因的启动子,插入萤光素酶报告基因载体,并检测启动子活性。方法：采用PCR技术从人肝癌细胞系HepG2基因组中扩增人p53启动子,插入萤光素酶报告基因载体pGL4．0-empty,将重组质粒转染293T、ZR75-1、HepG2、A549细胞,测定p53启动子的转录活性。结果：构建了p53启动子的萤光素酶报告基因;通过测序及质粒酶切鉴定,所构建的p53启动子正确;活性实验表明,报告基因在多种细胞中显示构建的p53启动子活性,并呈现一定的剂量效应;转录因子USF能以剂量效应方式提高p53报告基因的转录活性。结论：克隆了人p53启动子,为进一步研究调控p53的转录因子奠定了基础。     

Development of Capsicum EST–SSR markers for species identification and in silico mapping onto the tomato genome sequence

Capsicum spp. are widely cultivated for use as vegetables and spices. The Kihara Institute for Biological Research, Yokohama City University, Japan, has stocks of approximately 800 lines of Capsicum spp. collected from various regions of Central and South America, the regions of origin for Capsicum spp. In this study, 5,751 primer pairs for simple sequence repeat markers, based on 118,060 publicly available sequences of expressed sequence tags of Capsicum annuum, were designed and subjected to a similarity search against the genomic sequence of tomato, a model Solanaceae species. Nucleotide sequences spanning 2,245 C. annuum markers were successfully mapped onto the tomato genome, and 96 of these, which spanned the entire tomato genome, were selected for further analysis. In genotyping analysis, 60 out of the 77 markers that produced specific DNA amplicons showed polymorphism among the Capsicum lines examined. On the basis of the resulting data, the 192 tested lines were grouped into five main clusters. The additional sequencing analysis of the plastid genes, matK and rbcL, divided the resources into three groups. As a result, 19 marker loci exhibited genotypes specific to species and cluster, suggesting that the DNA markers are useful for species identification. Information on the DNA markers will contribute to Capsicum genetics, genomics, and breeding.     

Conjugation of Benzylvanillin and Benzimidazole Structure Improves DNA Binding with Enhanced Antileukemic Properties

Benzyl-o-vanillin and benzimidazole nucleus serve as important pharmacophore in drug discovery. The benzyl vanillin (2-(benzyloxy)-3-methoxybenzaldehyde) compound shows anti-proliferative activity in HL60 leukemia cancer cells and can effect cell cycle progression at G2/M phase. Its apoptosis activity was due to disruption of mitochondrial functioning. In this study, we have studied a series of compounds consisting of benzyl vanillin and benzimidazole structures. We hypothesize that by fusing these two structures we can produce compounds that have better anticancer activity with improved specificity particularly towards the leukemia cell line. Here we explored the anticancer activity of three compounds namely 2-(2-benzyloxy-3-methoxyphenyl)-1H-benzimidazole, 2MP, N-1-(2-benzyloxy-3-methoxybenzyl)-2-(2-benzyloxy-3-methoxyphenyl)-1H-benzimidazole, 2XP, and (R) and (S)-1-(2-benzyloxy-3-methoxyphenyl)-2, 2, 2-trichloroethyl benzenesulfonate, 3BS and compared their activity to 2-benzyloxy-3-methoxybenzaldehyde, (Bn1), the parent compound. 2XP and 3BS induces cell death of U937 leukemic cell line through DNA fragmentation that lead to the intrinsic caspase 9 activation. DNA binding study primarily by the equilibrium binding titration assay followed by the Viscosity study reveal the DNA binding through groove region with intrinsic binding constant 7.39 µM/bp and 6.86 µM/bp for 3BS and 2XP respectively. 2XP and 3BS showed strong DNA binding activity by the UV titration method with the computational drug modeling showed that both 2XP and 3BS failed to form any electrostatic linkages except via hydrophobic interaction through the minor groove region of the nucleic acid. The benzylvanillin alone (Bn1) has weak anticancer activity even after it was combined with the benzimidazole (2MP), but after addition of another benzylvanillin structure (2XP), stronger activity was observed. Also, the combination of benzylvanillin with benzenesulfonate (3BS) significantly improved the anticancer activity of Bn1. The present study provides a new insight of benzyl vanillin derivatives as potential anti-leukemic agent.     

不同剂量地佐辛用于腹腔镜妇科手术超前镇痛的效果观察

目的：观察不同剂量地佐辛用于腹腔镜妇科手术超前镇痛的效果。方法：将90例ASAI．II级、年龄18~60岁拟行腹腔镜妇科手术的患者随机分成3组,每组30例,A组给予地佐辛0．1mg／kg开皮前15rain静脉注射;B组给予地佐辛0．15mg／kg开皮前15min静脉注射;C组给予地佐辛0．2mg／kg开皮前15min静脉注射,采用VAS评分评估术后镇痛效果并观察术后辅助镇痛药物的使用和不良反应的发生情况。结果：B、c组术后2、4、6、8h的VAS评分明显低于A组（P〈0．05）;C组术后2、4h的Ramsay评分明显高于A、B组（P〈0.05）;A组术后辅助镇痛药的使用率明显高于B组和C组（P／0．05）;3组不良反应的发生率比较均无统计学差异（P〉0．05）。结论：开皮前15rain静注地佐辛0．15mg／kg用于腹腔镜妇科手术镇痛效果好,且不增加不良反应的发生率。